🇺🇸 FDA
Pipeline program

TG-0054 combined with G-CSF

TG-0054-04

Phase 2 small_molecule completed

Quick answer

TG-0054 combined with G-CSF for Multiple Myeloma is a Phase 2 program (small_molecule) at Structure Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Structure Therapeutics
Indication
Multiple Myeloma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials